Europe Edging Towards Electronic Prescribing - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Europe Edging Towards Electronic Prescribing
Electronic prescribing has grown strongly in the US but its future as a European-wide approach in healthcare has been uncertain; new regulatory interest could change the playing field.

Pharmaceutical Technology Europe
Volume 23, Issue 10

The pharma industry's point of view

Electronic prescribing has important implications for the pharmaceutical industry because it will represent a change in physician behaviour. Pharma companies will need to determine how this trend will affect the prescribing of their products and ensure they provide physicians with adequate support (9). To maintain relationships with physicians, companies will need to be seen as experts in the electronic prescribing field themselves. In the US market, pharmaceutical companies have had to adapt very quickly to changes in physician attitudes and assess the strategy of their sales representatives who interact with physicians. In 2007, only 6% of physicians were prescribing electronically, but by 2010 this had jumped to over 30% (6)—and financial incentives from the US government to drive uptake mean that this trend will increase.

In Europe, although there has been discussion of the issues around electronic prescribing, there are few obvious signs that the pharma industry is preparing for large-scale uptake. It is inevitable that it will be eventually adopted, but no timeline can be predicted at the moment. The EMA's workshop will provide important direction to those interested in the concept and provide an official framework for the field to develop. Based on these outcomes, the European pharmaceutical industry will need to rapidly adapt to the changing prescribing environment. However, its knowledge of markets where electronic prescribing has proved a success should provide suitable experience to deal with changes in the European healthcare environment.


1. EMA, "Software development companies invited to express interest in workshop on electronic prescribing", News Release (UK, 2011).

2. Whitener Law Firm, P.A, "Prescription mistakes" (US, 2011)., accessed 9 Sept. 2011.

3. E. Cohen, "Don't be a victim of pharmacy errors", CNN (2007)., accessed 9 Sept. 2011.

4. Guild of Healthcare Pharmacists, "Pharmacists EQUIP doctors with safety net when it comes to prescribing in hospital" (2009)., accessed 9 Sept. 2011.

5. PMR, "Czech e-prescription system paperless only in name" (2011)., accessed 9 Sept. 2011.

6. E. John. "Pharma must prepare for e-prescribing closeup", Medical, Marketing & media (2011)., accessed 9 Sept. 2011.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology Europe,
Click here